Mouse Tril/1200009O22Rik/AI316813 ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_025817)

Cat. No.: pGMAAV000551
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Mouse Tril/1200009O22Rik/AI316813 Adeno-associated virus expression plasmid (ITR-vector) for Tril AAV packaging, Tril AAV production.The purified Mouse Tril/1200009O22Rik/AI316813 AAV particle serves as an invaluable asset for in-depth in vivo Tril studies, mechanism of action (MOA) research, and the evolution of Tril-associated gene therapy strategies.

Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAAV000551
Gene Name Tril
Accession Number NM_025817
Gene ID 66873
Species Mouse
Product Type Adeno-associate virus(AAV) plasmid (overexpression)
Insert Length 2430 bp
Gene Alias 1200009O22Rik,AI316813,mKIAA0644
Fluorescent Reporter Null
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGAGGGTGTGGGTGCCGTGCGCTTCTGGCTCGTGGTGTGCGGCTGCCTGGCGTTCCCGCCGCGGGCCGAGTCCGTGTGCCCGGAGCGCTGCGACTGCCAGCACCCCCAACATCTCCTATGCACCAACAGGGGACTTCGCGCTGTACCCAAGACCAGCTCGCTGCCTAGTCCCCAGGACGTGCTCACCTACAGCCTAGGCGGCAACTTCATCACCAACATCACCGCCTTCGACTTCCACCGTCTGGGGCAGCTCAGACGGCTGGATCTGCAGTACAACCAGATCCGTTCTCTCCACCCCAAGACCTTCGAGAAGCTCTCACGACTAGAGGAGCTGTACCTGGGGAACAACCTCTTGCAGGCGCTCGTTCCTGGCACGTTGGCTCCGCTGCGCAAGTTGCGCATCCTTTACGCCAACGGCAACGAGATTGGACGCCTGAGTCGCGGGTCCTTCGAGGGCCTGGAGAGTTTGGTCAAGCTACGGCTGGACGGGAACGTGCTGGGAGCGCTGCCGGACGCGGTCTTCGCTCCCCTGGGCAACCTGCTCTACCTACACCTGGAATCTAACCGGATCCGTTTTTTGGGCAAGAACGCCTTCAGCCAGCTGGGTAAGCTTCGATTCCTCAATCTCTCGGCCAACGAGCTGCAACCCTCTCTGCGCCACGCGGCCACCTTTGTCCCTCTGCGCTCCCTCTCTACTCTCATCCTCTCAGCCAACAGCCTACAGCACCTCGGCCCCCGCGTCTTCCAGCACCTGCCACGCCTAGGCCTGCTCTCCCTCAGTGGAAACCAGCTCACGCACCTCGCCCCAGAGGCCTTTTGGGGACTGGAGGCCCTACGTGAGCTGCGCCTGGAAGGTAACCGGCTGAACCAGCTCCCCCTGACACTGCTGGAGCCTCTGCACAGCTTGGAGGCACTAGACCTGAGTGGCAATGAGCTTTCTGCTCTGCACCCTGCCACCTTTGGCCACCAGGGCCGGCTCCGTGAGCTCAGCCTGCGCGACAACGCGCTCAGCGCCCTTTCTGGGGACATCTTTGCCGCCAGTCCGGCTCTCTACCGGCTGGATCTAGACGGCAATGGTTGGACCTGCGACTGCCGGTTGCGGGGTCTGAAACGCTGGATGGGCAACTGGCATTCTCAGGGTCGCCTCCTTACGGTCTTCGTGCAGTGTCGCCACCCCCCGGCCCTGCGGGGCAAGTACCTGGATTACCTGGATGACCAACTGCTGCAGAATGGGTCTTGCGTGGATCCCTCACCTTCCCCTACAGCAGGCAGTAGGCAGTGGCCGCTACCCACATCGTCAGAAGAGGGGATGACGCCCCCTGCAGGCCTCTCGCAGGAGCTACCACTGCAGCCGCAGCCGCAGCCCCAGCAGCGGGGAAGACTTCTACCAGGAGTGGCCTGGGGTGGGGCTGCCAAGGAACTGGTGGGCAACCGCAGCGCATTAAGGTTGAGCCGGCGGGGACCAGGTCCCCATCAGGGCCCCTCTGCTGCGGCTCCGGGCTCTGCCCCACAGTCCTTGGACCTGCACGAGAAGCCGGGGAGAGGACGTCACACCCGAGCCAATCTCTCCCAGACGGAGCCCACCCCGACGTCTGAGCCCGCCTCTGGGACACCATCTGCCAGAGACAGCTGGCAGCGCGCAGCAAAGCAGCGCCTAGCGTCCGAGCAGCAAGAGAGCGCAGTCCAGTCCGTTAGTGGGGTTGGTTTGCCACCTCTGGTGTCTGACCCCTGTGACTTCAACAAATTCATTCTGTGCAACCTGACAGTAGAGGCGGTGAGCGCCAACAGCGCCTCGGTGCGCTGGGCGGTTCGCGAACACCGCAGTCCCCGGCCGCAGGGCGGCGCACGCTTCCGCCTGCTTTTCGACCGCTTTGGCCAGCAGCCCAAGTTCCAGCGCTTCGTCTACCTGCCGGAGCGCAGCGACTCGGCCACGCTGCACGAGCTGCGCGGAGACACCCCCTACCTAGTATGCGTGGAGGGTGTGCTCGGGGGTCGCGTTTGCCCCGTGGCCCCCCGAGACCACTGCGCAGGGTTAGTAACCCTGCCAGAGGCAGGAGGTCGAGGTGGCGTCGACTACCAGCTCCTGACCTTGGTCTTGCTGGCTGTCAACGCGCTTCTGGTGCTCCTGGCACTGGCAGCCTGGGGATCGCGATGGCTGCGGAGGAAGCTGCGTGCCAGGCGGAAGGGAGGGGCCCCGGTCCACGTTCGCCACATGTACTCCACCCGACGGCCACTGCGCTCCATGGGCACTGGTGTGTCCGCGGACTTCTCAGGCTTCCAGTCGCACCGTCCCCGCACCACCGTGTGCGCGCTCAGCGAGGCCGACCTCATTGAGTTCCCCTGCGACCGCTTCATGGACAGCACCGGCGGTGGTACCAGTGGCAGCTTGAGGCGGGAGGATCACCTCTTGCAAAGATTCGCTGACTAG
ORF Protein Sequence MEGVGAVRFWLVVCGCLAFPPRAESVCPERCDCQHPQHLLCTNRGLRAVPKTSSLPSPQDVLTYSLGGNFITNITAFDFHRLGQLRRLDLQYNQIRSLHPKTFEKLSRLEELYLGNNLLQALVPGTLAPLRKLRILYANGNEIGRLSRGSFEGLESLVKLRLDGNVLGALPDAVFAPLGNLLYLHLESNRIRFLGKNAFSQLGKLRFLNLSANELQPSLRHAATFVPLRSLSTLILSANSLQHLGPRVFQHLPRLGLLSLSGNQLTHLAPEAFWGLEALRELRLEGNRLNQLPLTLLEPLHSLEALDLSGNELSALHPATFGHQGRLRELSLRDNALSALSGDIFAASPALYRLDLDGNGWTCDCRLRGLKRWMGNWHSQGRLLTVFVQCRHPPALRGKYLDYLDDQLLQNGSCVDPSPSPTAGSRQWPLPTSSEEGMTPPAGLSQELPLQPQPQPQQRGRLLPGVAWGGAAKELVGNRSALRLSRRGPGPHQGPSAAAPGSAPQSLDLHEKPGRGRHTRANLSQTEPTPTSEPASGTPSARDSWQRAAKQRLASEQQESAVQSVSGVGLPPLVSDPCDFNKFILCNLTVEAVSANSASVRWAVREHRSPRPQGGARFRLLFDRFGQQPKFQRFVYLPERSDSATLHELRGDTPYLVCVEGVLGGRVCPVAPRDHCAGLVTLPEAGGRGGVDYQLLTLVLLAVNALLVLLALAAWGSRWLRRKLRARRKGGAPVHVRHMYSTRRPLRSMGTGVSADFSGFQSHRPRTTVCALSEADLIEFPCDRFMDSTGGGTSGSLRREDHLLQRFAD

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector vGMAAV000551 Mouse Tril Adeno-associate virus(AAV) particle




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.